JBIO
Jade Biosciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$13.83
+2.67%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.73
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 10, 2026
- EPS actual
- -$0.76
- EPS estimate
- -$0.64
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 1
- Avg surprise (4Q)
- +15.6%
- Revenue beats (12Q)
- —
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $60
- PT range
- $47 – $77
- Analysts
- 3
3 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 10, 2026 | -$0.64 | -$0.76 | Miss -19.42% | — |
| May 7, 2026 | -$0.52 | -$0.57 | Miss -9.62% | — |
| Mar 6, 2026 | -$0.45 | -$0.11 | Beat 75.56% | — |
| Nov 13, 2025 | -$0.57 | -$0.48 | Beat 15.79% | — |
| Aug 13, 2025 | -$0.43 | -$0.86 | Miss -100.00% | — |
| Apr 25, 2025 | -$8.40 | -$0.09 | Beat 98.93% | — |
| Mar 27, 2025 | -$0.19 | -$0.19 | In line | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026